by admin | May 4, 2024 | Article
March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024. For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf
by admin | May 4, 2024 | Article
March 21, 2024 – Lupus Canada is honoured to support the Dr. Murray B. Urowitz Chair in Lupus Research. For over 50 years, Dr. Murray Urowitz led the world in lupus diagnosis, treatment, research and education. The Dr. Murray B. Urowitz Chair in Lupus Research...
by admin | May 4, 2024 | Article
March 25, 2024 – The William Birchall Foundation has donated $25,000 in 2024 in support of the Lupus Canada Scholarship program. The 2024 Lupus Canada William Birchall Foundation Scholarship will be offering ten (10) one-time scholarships of $2,500 CAD to...
by admin | May 4, 2024 | Article
March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024. The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is...
by admin | May 4, 2024 | Article
February 15, 2024 – Lupus Canada is honoured to be a member of the CIAN group. Together our goal is to protect more Canadians to improve the quality of life and significantly reduce hospitalization for vulnerable people. On page 60 of the Heal Canada Digital...
by admin | Apr 22, 2024 | Article
This is an anxious time across Canada and all over the world; keep in mind that most people who become infected have mild or even no symptoms. The main goal of all current recommendations is to slow the spread of the virus. People with lupus may ask: What precautions...
